TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

25.00$ +1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Beam Therapeutics Inc (BEAM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 140 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BEAM
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 52 61 378 64 140
0.0 34 55 103 232 312 437 368 22
0.0 -34 -55 -103 -180 -251 378 -304 117
5.9 34 55 103 387 312 437 368 410
2.0 12 21 30 57 88 117 112 114
8.6 12 21 30 212 88 554 112 501
-8.6 -46 -75 -133 -392 -338 -176 -416 -384
0.0 0.0 0.2 1.6 0.0 15 47 49 44
-8.7 -117 -78 -195 -371 -286 -131 -377 -80
0.5 -71 0.1 62 -29 3.4 1.4 0.0
-8.7 -115 -78 -195 -371 -289 -133 -377 -80
-8.6 -45 -72 -128 -230 -272 -102 -355 -30

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?